董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Ajay Rajpal Director 53 未披露 未持股 2023-06-28
Wei Wen Kelvin Chen Chief Executive Officer, Executive Director 39 39.00万美元 未持股 2023-06-28
Alfred Lim Executive Director 72 未披露 未持股 2023-06-28
Eric Lew Director 50 未披露 未持股 2023-06-28
Kong Yew Wong Director 48 未披露 未持股 2023-06-28

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Wei Wen Kelvin Chen Chief Executive Officer, Executive Director 39 39.00万美元 未持股 2023-06-28
Steven John Sobak Chief Financial Officer 76 11.00万美元 未持股 2023-06-28

董事简历

中英对照 |  中文 |  英文
Ajay Rajpal

Ajay Rajpal自2019年3月27日起担任我们的董事。Rajpal先生是英国特许会计师协会(Institute of Chartered Accountants in England&Wales ICAEW)的特许会计师。职业生涯中,他获得了在美国、欧洲、中东和远东地区开发的广泛的商业经验,尤其专注于并购、财务管理和破产/重组。任职资格后,Rajpal先生曾担任多个与金融相关的职位,涉及在美国,欧洲,中东和远东地区工作。自2011年以来,Rajpal先生经营自己的咨询业务NAS Corporate Services Ltd,为公司提供各种企业服务,例如协助其上市前的融资,IPO过程和上市后的管理。Rajpal先生曾管理AIM的首次公开募股过程,并协助为两个业务提供相关资金,即New Trend Lifestyle Group plc(在亚洲各地提供风水产品和服务)和Zibao Metals Recycling Group plc,一家总部位于香港和中国的金属回收公司。他目前担任New Trend Lifestyle Group plc、Zibao Metals Recycling Group plc、Early Equity plc的非执行董事。Rajpal先生协助AIM上市的MNC Strategic Investments plc(“;MNC Strategic”;)重组其债务并监督公司不良资产的处置。在处置其主要资产后,MNC Strategic成为AIM的一家投资公司,寻求在电信、媒体和技术部门进行收购。Rajpal先生还在伦敦证券交易所上市了一家特殊目的收购公司Grand Vision Media Holdings plc,该公司成功完成了对中国香港/中国香港一家户外媒体业务的反向收购。Rajpal先生此前是魔线集团的独立董事,该公司是一家美国公司,在纳斯达克上市,在中国拥有互联网业务。


Ajay Rajpal,is a Chartered Accountant and member of the Institute of Chartered Accountants in England & Wales (ICAEW). During his career, he has gained broad-ranging commercial experience developed in the US, Europe, Middle East and Far East, with a particular focus on M&A, financial management and insolvency/restructuring. Post qualification, Mr. Rajpal held a number of finance-related roles which involved working for periods in the US, Europe, Middle East and Far East. Since 2011, Mr. Rajpal has run his own consultancy business, NAS Corporate Services Ltd, providing companies with various corporate services, such as assistance with their pre-IPO funding, the IPO process and post IPO management. Mr. Rajpal has project managed the initial public offering process and assisted with the associated funding of two businesses on AIM, namely New Trend Lifestyle Group Plc, which provides Feng Shui products and services across Asia, and Zibao Metals Recycling Group Plc, a Hong Kong and China based metals recycling company. He currently is a director of Grand Vision Media Holdings Plc, RC365 Holding Plc and Essentially Group Plc, all of which are listed on the London Stock Exchange. Mr. Rajpal was previously an independent director of Moxian, Inc., a US company with a China based internet business listed on Nasdaq.
Ajay Rajpal自2019年3月27日起担任我们的董事。Rajpal先生是英国特许会计师协会(Institute of Chartered Accountants in England&Wales ICAEW)的特许会计师。职业生涯中,他获得了在美国、欧洲、中东和远东地区开发的广泛的商业经验,尤其专注于并购、财务管理和破产/重组。任职资格后,Rajpal先生曾担任多个与金融相关的职位,涉及在美国,欧洲,中东和远东地区工作。自2011年以来,Rajpal先生经营自己的咨询业务NAS Corporate Services Ltd,为公司提供各种企业服务,例如协助其上市前的融资,IPO过程和上市后的管理。Rajpal先生曾管理AIM的首次公开募股过程,并协助为两个业务提供相关资金,即New Trend Lifestyle Group plc(在亚洲各地提供风水产品和服务)和Zibao Metals Recycling Group plc,一家总部位于香港和中国的金属回收公司。他目前担任New Trend Lifestyle Group plc、Zibao Metals Recycling Group plc、Early Equity plc的非执行董事。Rajpal先生协助AIM上市的MNC Strategic Investments plc(“;MNC Strategic”;)重组其债务并监督公司不良资产的处置。在处置其主要资产后,MNC Strategic成为AIM的一家投资公司,寻求在电信、媒体和技术部门进行收购。Rajpal先生还在伦敦证券交易所上市了一家特殊目的收购公司Grand Vision Media Holdings plc,该公司成功完成了对中国香港/中国香港一家户外媒体业务的反向收购。Rajpal先生此前是魔线集团的独立董事,该公司是一家美国公司,在纳斯达克上市,在中国拥有互联网业务。
Ajay Rajpal,is a Chartered Accountant and member of the Institute of Chartered Accountants in England & Wales (ICAEW). During his career, he has gained broad-ranging commercial experience developed in the US, Europe, Middle East and Far East, with a particular focus on M&A, financial management and insolvency/restructuring. Post qualification, Mr. Rajpal held a number of finance-related roles which involved working for periods in the US, Europe, Middle East and Far East. Since 2011, Mr. Rajpal has run his own consultancy business, NAS Corporate Services Ltd, providing companies with various corporate services, such as assistance with their pre-IPO funding, the IPO process and post IPO management. Mr. Rajpal has project managed the initial public offering process and assisted with the associated funding of two businesses on AIM, namely New Trend Lifestyle Group Plc, which provides Feng Shui products and services across Asia, and Zibao Metals Recycling Group Plc, a Hong Kong and China based metals recycling company. He currently is a director of Grand Vision Media Holdings Plc, RC365 Holding Plc and Essentially Group Plc, all of which are listed on the London Stock Exchange. Mr. Rajpal was previously an independent director of Moxian, Inc., a US company with a China based internet business listed on Nasdaq.
Wei Wen Kelvin Chen

温伟 Kelvin Chen,自2019年起担任EUDA首席执行官、创始人和执行董事。在此之前的2012年至2017年,陈博士在新加坡最大的上市医疗保健公司Healthway Medical Group(Healthway)工作,该公司拥有100多家医疗诊所。在Healthway任职期间,他最初担任集团营销经理(2012年至2014年),后来晋升为成人专科和CMO部门主管(2014年至2015年),专科部门总经理(2015年),并最终担任副总裁(2015年至2017年),负责企业的运营和增长,为公司2015年出色的收入增长做出了贡献。陈博士在医疗保健和企业销售部门的重组和战略制定中发挥了重要作用,以实现Healthway董事会设定的年度目标。在Healthway任职期间,陈博士看到了传统医疗保健基础设施的差距,以及推动整个健康生态系统数字化的技术创新机会,促使他建立了Kent Ridge Health。陈博士的职业生涯始于新加坡警察部队(SPF),当时他是一名警官,管理业务的经验构成了他管理技能的基础。他曾担任SPF在新兴技术、管理信息系统和运营方面的IT顾问。在担任这一职务期间,他帮助推动了SPF从过时的全组织技术向尖端、高成本效益的业务解决方案过渡的全面改革,这些解决方案显著提高了效率,降低了开支,并优化了数据完整性和安全性。陈博士拥有南澳大利亚大学工商管理博士学位和格林威治大学计算机科学荣誉理学学士学位。


Wei Wen Kelvin Chen,Since 2019, he has served as the Chief Executive Officer and founder as well as the Executive Director at EUDA. Previously, from 2012 to 2017, Dr. Chen worked at Healthway Medical Group (Healthway), the largest listed healthcare company in Singapore with more than 100 medical clinics. While at Healthway, he started off as the Group Marketing Manager (from 2012 to 2014), was promoted to the Head of the Adult Specialist and CMO department (from 2014 to 2015), General Manager of the Specialist Division (2015) and eventually served as the Vice President (from 2015 to 2017), where he was responsible for the enterprise's operations and growth, contributing to its exceptional revenue growth in 2015. Dr, Chen was instrumental in restructuring exercise and strategizing the Healthcare and Corporate Sales division to achieve the annual targets set by the board of Healthway, While at Healthway, Dr. Chen saw the gaps within the traditional healthcare infrastructure and an opportunity for technological innovation to propel digitalization across the entire health ecosystem, spurring him to establish Kent Ridge Health. Dr. Chen started his career with the Singapore Police Force (SPF) as a police officer, where the experience of managing operations formed the foundations of his management skills. He served as SPF's IT consultant on emerging technologies, managing information systems and operations. In this role, he was instrumental in facilitating the overhaul of SPF's transition from outdated organization-wide technologies to cutting edge, cost-effective business solutions that dramatically improved efficiency, decreased expenses, and optimized data integrity and safety. Dr. Chen holds a Doctorate in Business Administration from the University of South Australia and a Bachelor of Science, with honors, in Computer Science from the University of Greenwich.
温伟 Kelvin Chen,自2019年起担任EUDA首席执行官、创始人和执行董事。在此之前的2012年至2017年,陈博士在新加坡最大的上市医疗保健公司Healthway Medical Group(Healthway)工作,该公司拥有100多家医疗诊所。在Healthway任职期间,他最初担任集团营销经理(2012年至2014年),后来晋升为成人专科和CMO部门主管(2014年至2015年),专科部门总经理(2015年),并最终担任副总裁(2015年至2017年),负责企业的运营和增长,为公司2015年出色的收入增长做出了贡献。陈博士在医疗保健和企业销售部门的重组和战略制定中发挥了重要作用,以实现Healthway董事会设定的年度目标。在Healthway任职期间,陈博士看到了传统医疗保健基础设施的差距,以及推动整个健康生态系统数字化的技术创新机会,促使他建立了Kent Ridge Health。陈博士的职业生涯始于新加坡警察部队(SPF),当时他是一名警官,管理业务的经验构成了他管理技能的基础。他曾担任SPF在新兴技术、管理信息系统和运营方面的IT顾问。在担任这一职务期间,他帮助推动了SPF从过时的全组织技术向尖端、高成本效益的业务解决方案过渡的全面改革,这些解决方案显著提高了效率,降低了开支,并优化了数据完整性和安全性。陈博士拥有南澳大利亚大学工商管理博士学位和格林威治大学计算机科学荣誉理学学士学位。
Wei Wen Kelvin Chen,Since 2019, he has served as the Chief Executive Officer and founder as well as the Executive Director at EUDA. Previously, from 2012 to 2017, Dr. Chen worked at Healthway Medical Group (Healthway), the largest listed healthcare company in Singapore with more than 100 medical clinics. While at Healthway, he started off as the Group Marketing Manager (from 2012 to 2014), was promoted to the Head of the Adult Specialist and CMO department (from 2014 to 2015), General Manager of the Specialist Division (2015) and eventually served as the Vice President (from 2015 to 2017), where he was responsible for the enterprise's operations and growth, contributing to its exceptional revenue growth in 2015. Dr, Chen was instrumental in restructuring exercise and strategizing the Healthcare and Corporate Sales division to achieve the annual targets set by the board of Healthway, While at Healthway, Dr. Chen saw the gaps within the traditional healthcare infrastructure and an opportunity for technological innovation to propel digitalization across the entire health ecosystem, spurring him to establish Kent Ridge Health. Dr. Chen started his career with the Singapore Police Force (SPF) as a police officer, where the experience of managing operations formed the foundations of his management skills. He served as SPF's IT consultant on emerging technologies, managing information systems and operations. In this role, he was instrumental in facilitating the overhaul of SPF's transition from outdated organization-wide technologies to cutting edge, cost-effective business solutions that dramatically improved efficiency, decreased expenses, and optimized data integrity and safety. Dr. Chen holds a Doctorate in Business Administration from the University of South Australia and a Bachelor of Science, with honors, in Computer Science from the University of Greenwich.
Alfred Lim

Alfred Lim于1978年在欧洲顶级化学品和制药公司之一的May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd开始了他的职业生涯,之后于1990年进入Neste Chemicals Trading Singapore Pte Ltd,担任董事总经理,负责向美国、欧洲和亚洲的公司销售和营销。1994年至2002年间,他担任北欧化工新加坡私人有限公司董事总经理,管理该公司的亚太办事处和分销商。在林先生的职权范围内,新加坡北欧化工荣获1998/1999年度财政部颁发的国际贸易奖、贸易和工业部颁发的认可国际交易商地位和新加坡股东基金最高回报1000强。2002年,Lim与他人共同创立了马来西亚化学品分销商Akashi Sdn Bhd,该公司后来被出售给East Asiatic Chemicals/Brenntag。从2006年到2018年,林先生担任安阳集团的高级顾问,在越南为国际卫浴产品品牌建立了分销网络。自2018年以来,他一直担任全球最大的越南卫浴制造商乐家集团的顾问。Alfred于1976年在新加坡大学获得化学理学士(荣誉)学位,1986年在新加坡管理学院获得市场营销研究生文凭。


Alfred Lim,started his career in 1978 with May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd, one of Europe's top chemicals and pharmaceutical companies, before moving on to Neste Chemicals Trading Singapore Pte Ltd in 1990, where he was the Managing Director responsible for sales and marketing to companies in United States, Europe, and Asia. Between 1994 to 2002, he was the managing director of Borealis Singapore Pte Ltd, managing the company's Asia Pacific offices and distributors. Under Mr. Lim's remit, Borealis Singapore was awarded the International Trade Award from Ministry of Finance, Approved International Trader status from Ministry of Trade & Industry and Singapore 1,000 Ranking for Highest Returns on Shareholders' Funds for year 1998/1999. In 2002, Mr Lim co-founded Akashi Sdn Bhd, a Malaysian distributor for chemicals which was later sold to East Asiatic Chemicals/Brenntag. From 2006 to 2018, Mr. Lim acted as a senior consultant to An Duong Group, setting up a distributor network in Vietnam for international bathroom product brands. Since 2018, he has been a consultant to Roca Group, the world's largest sanitary ware manufacturer for Vietnam. Alfred received his Bachelor of Science (Honors) degree in Chemistry from the University of Singapore in 1976, Graduate diploma in Marketing from Singapore Institute of Management in 1986.
Alfred Lim于1978年在欧洲顶级化学品和制药公司之一的May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd开始了他的职业生涯,之后于1990年进入Neste Chemicals Trading Singapore Pte Ltd,担任董事总经理,负责向美国、欧洲和亚洲的公司销售和营销。1994年至2002年间,他担任北欧化工新加坡私人有限公司董事总经理,管理该公司的亚太办事处和分销商。在林先生的职权范围内,新加坡北欧化工荣获1998/1999年度财政部颁发的国际贸易奖、贸易和工业部颁发的认可国际交易商地位和新加坡股东基金最高回报1000强。2002年,Lim与他人共同创立了马来西亚化学品分销商Akashi Sdn Bhd,该公司后来被出售给East Asiatic Chemicals/Brenntag。从2006年到2018年,林先生担任安阳集团的高级顾问,在越南为国际卫浴产品品牌建立了分销网络。自2018年以来,他一直担任全球最大的越南卫浴制造商乐家集团的顾问。Alfred于1976年在新加坡大学获得化学理学士(荣誉)学位,1986年在新加坡管理学院获得市场营销研究生文凭。
Alfred Lim,started his career in 1978 with May & Baker Ltd/Rhone Poulenc Singapore Pte Ltd, one of Europe's top chemicals and pharmaceutical companies, before moving on to Neste Chemicals Trading Singapore Pte Ltd in 1990, where he was the Managing Director responsible for sales and marketing to companies in United States, Europe, and Asia. Between 1994 to 2002, he was the managing director of Borealis Singapore Pte Ltd, managing the company's Asia Pacific offices and distributors. Under Mr. Lim's remit, Borealis Singapore was awarded the International Trade Award from Ministry of Finance, Approved International Trader status from Ministry of Trade & Industry and Singapore 1,000 Ranking for Highest Returns on Shareholders' Funds for year 1998/1999. In 2002, Mr Lim co-founded Akashi Sdn Bhd, a Malaysian distributor for chemicals which was later sold to East Asiatic Chemicals/Brenntag. From 2006 to 2018, Mr. Lim acted as a senior consultant to An Duong Group, setting up a distributor network in Vietnam for international bathroom product brands. Since 2018, he has been a consultant to Roca Group, the world's largest sanitary ware manufacturer for Vietnam. Alfred received his Bachelor of Science (Honors) degree in Chemistry from the University of Singapore in 1976, Graduate diploma in Marketing from Singapore Institute of Management in 1986.
Eric Lew

Eric Lew在毕马威会计师事务所担任了近3年的审计师,之后加入Wong Fong Industries Ltd,担任了16年的执行董事,并一直担任董事会成员。他于2019年3月至2022年7月担任Y Ventures Group Ltd执行主席,负责推动该电商集团的战略方向和增长,并为管理层提供指导。自2023年1月以来,卢先生一直担任Eggriculture Foods Ltd的董事会成员。他也是WMRAS(新加坡美国废物管理及回收协会)执行委员会、Northlight学校董事会和南大南洋商学院校友理事会的成员。2016年,卢先生被提名为《海峡时报》年度新加坡人,以表彰他对新加坡中小型实体(SME)和创新的贡献。卢先生拥有新加坡南洋理工大学会计学学士学位,辅修银行和金融。


Eric Lew,started his career as an auditor with KPMG LLP for nearly 3 years before joining Wong Fong Industries Ltd where he served for 16 years as the Executive Director and remains as a board member. He served as the Executive Chairman of Y Ventures Group Ltd from March 2019 to July 2022, where his role was to drive the e-commerce group's strategic direction and growth and to provide mentorship to management. Mr. Lew has served on the board of Eggriculture Foods Ltd since January 2023. He also serves on Executive Committee Board of WMRAS (Waste Management and Recycle Association of Singapore), the Board of Directors of Northlight School, and the NTU Nanyang Business School Alumni Board. In 2016, Mr. Lew was nominated for the Straits Times' Singaporean of the Year for his contribution to small and medium-sized entities (SMEs) and innovation in Singapore. Mr. Lew has a Bachelor's Degree in Accountancy with a Minor in Banking and Finance from the Nanyang Technological University of Singapore.
Eric Lew在毕马威会计师事务所担任了近3年的审计师,之后加入Wong Fong Industries Ltd,担任了16年的执行董事,并一直担任董事会成员。他于2019年3月至2022年7月担任Y Ventures Group Ltd执行主席,负责推动该电商集团的战略方向和增长,并为管理层提供指导。自2023年1月以来,卢先生一直担任Eggriculture Foods Ltd的董事会成员。他也是WMRAS(新加坡美国废物管理及回收协会)执行委员会、Northlight学校董事会和南大南洋商学院校友理事会的成员。2016年,卢先生被提名为《海峡时报》年度新加坡人,以表彰他对新加坡中小型实体(SME)和创新的贡献。卢先生拥有新加坡南洋理工大学会计学学士学位,辅修银行和金融。
Eric Lew,started his career as an auditor with KPMG LLP for nearly 3 years before joining Wong Fong Industries Ltd where he served for 16 years as the Executive Director and remains as a board member. He served as the Executive Chairman of Y Ventures Group Ltd from March 2019 to July 2022, where his role was to drive the e-commerce group's strategic direction and growth and to provide mentorship to management. Mr. Lew has served on the board of Eggriculture Foods Ltd since January 2023. He also serves on Executive Committee Board of WMRAS (Waste Management and Recycle Association of Singapore), the Board of Directors of Northlight School, and the NTU Nanyang Business School Alumni Board. In 2016, Mr. Lew was nominated for the Straits Times' Singaporean of the Year for his contribution to small and medium-sized entities (SMEs) and innovation in Singapore. Mr. Lew has a Bachelor's Degree in Accountancy with a Minor in Banking and Finance from the Nanyang Technological University of Singapore.
Kong Yew Wong

Kong Yew Wong,自2021年9月起担任D'Mace Pty Ltd(澳大利亚)集团首席执行官,负责公司治理、战略方向和业绩。他还在与东盟和世旅组织的几项倡议中担任首席顾问。黄博士还自2020年11月起担任澳大利亚E-Plus有限公司的执行董事。他也是一位国际主旨发言人,在亚洲的主要国际会议上露面,并在报纸和电视新闻中做专题报道(在Astro Awani、Berita、TV2等接受个人采访)。从2017年4月到2020年9月,黄博士担任马来西亚私人公司DYBIOTECH Bhd.的首席执行官,该公司向马来西亚推广美容旅游。黄博士于1996年12月获得西密歇根大学经济学工商管理学士学位。他于2000年12月获得马来西亚普特拉大学经济学硕士学位。Wong博士于2004年12月在斯特拉斯克莱德大学获得经济学博士学位。


Kong Yew Wong,has been serving as the Group CEO at D'Mace Pty Ltd (Australian) since September 2021, responsible for the company's corporate governance, strategic directions and performance. He has also served as the lead consultant in several initiatives with ASEAN and UNWTO. Dr. Wong has also been serving as the Executive Director of E-Plus Ltd. in Australia since November 2020. He is also an international keynote speaker with appearances at major international conference in Asia, and features in newspapers and TV news (with personal interview at Astro Awani, Berita, TV2 etc). From April 2017 to September 2020, Dr. Wong served as the CEO at DYBIOTECH Bhd., a privately-held company in Malaysia that promotes beauty tourism to Malaysia. Dr. Wong received his Bachelor of Business Administration degree in Economics from Western Michigan University in December 1996. He received his Master of Economics from Universiti Putra Malaysia in December 2000. Dr. Wong received his Ph.D. degree in Economics from Strathclyde University in December 2004.
Kong Yew Wong,自2021年9月起担任D'Mace Pty Ltd(澳大利亚)集团首席执行官,负责公司治理、战略方向和业绩。他还在与东盟和世旅组织的几项倡议中担任首席顾问。黄博士还自2020年11月起担任澳大利亚E-Plus有限公司的执行董事。他也是一位国际主旨发言人,在亚洲的主要国际会议上露面,并在报纸和电视新闻中做专题报道(在Astro Awani、Berita、TV2等接受个人采访)。从2017年4月到2020年9月,黄博士担任马来西亚私人公司DYBIOTECH Bhd.的首席执行官,该公司向马来西亚推广美容旅游。黄博士于1996年12月获得西密歇根大学经济学工商管理学士学位。他于2000年12月获得马来西亚普特拉大学经济学硕士学位。Wong博士于2004年12月在斯特拉斯克莱德大学获得经济学博士学位。
Kong Yew Wong,has been serving as the Group CEO at D'Mace Pty Ltd (Australian) since September 2021, responsible for the company's corporate governance, strategic directions and performance. He has also served as the lead consultant in several initiatives with ASEAN and UNWTO. Dr. Wong has also been serving as the Executive Director of E-Plus Ltd. in Australia since November 2020. He is also an international keynote speaker with appearances at major international conference in Asia, and features in newspapers and TV news (with personal interview at Astro Awani, Berita, TV2 etc). From April 2017 to September 2020, Dr. Wong served as the CEO at DYBIOTECH Bhd., a privately-held company in Malaysia that promotes beauty tourism to Malaysia. Dr. Wong received his Bachelor of Business Administration degree in Economics from Western Michigan University in December 1996. He received his Master of Economics from Universiti Putra Malaysia in December 2000. Dr. Wong received his Ph.D. degree in Economics from Strathclyde University in December 2004.

高管简历

中英对照 |  中文 |  英文
Wei Wen Kelvin Chen

温伟 Kelvin Chen,自2019年起担任EUDA首席执行官、创始人和执行董事。在此之前的2012年至2017年,陈博士在新加坡最大的上市医疗保健公司Healthway Medical Group(Healthway)工作,该公司拥有100多家医疗诊所。在Healthway任职期间,他最初担任集团营销经理(2012年至2014年),后来晋升为成人专科和CMO部门主管(2014年至2015年),专科部门总经理(2015年),并最终担任副总裁(2015年至2017年),负责企业的运营和增长,为公司2015年出色的收入增长做出了贡献。陈博士在医疗保健和企业销售部门的重组和战略制定中发挥了重要作用,以实现Healthway董事会设定的年度目标。在Healthway任职期间,陈博士看到了传统医疗保健基础设施的差距,以及推动整个健康生态系统数字化的技术创新机会,促使他建立了Kent Ridge Health。陈博士的职业生涯始于新加坡警察部队(SPF),当时他是一名警官,管理业务的经验构成了他管理技能的基础。他曾担任SPF在新兴技术、管理信息系统和运营方面的IT顾问。在担任这一职务期间,他帮助推动了SPF从过时的全组织技术向尖端、高成本效益的业务解决方案过渡的全面改革,这些解决方案显著提高了效率,降低了开支,并优化了数据完整性和安全性。陈博士拥有南澳大利亚大学工商管理博士学位和格林威治大学计算机科学荣誉理学学士学位。


Wei Wen Kelvin Chen,Since 2019, he has served as the Chief Executive Officer and founder as well as the Executive Director at EUDA. Previously, from 2012 to 2017, Dr. Chen worked at Healthway Medical Group (Healthway), the largest listed healthcare company in Singapore with more than 100 medical clinics. While at Healthway, he started off as the Group Marketing Manager (from 2012 to 2014), was promoted to the Head of the Adult Specialist and CMO department (from 2014 to 2015), General Manager of the Specialist Division (2015) and eventually served as the Vice President (from 2015 to 2017), where he was responsible for the enterprise's operations and growth, contributing to its exceptional revenue growth in 2015. Dr, Chen was instrumental in restructuring exercise and strategizing the Healthcare and Corporate Sales division to achieve the annual targets set by the board of Healthway, While at Healthway, Dr. Chen saw the gaps within the traditional healthcare infrastructure and an opportunity for technological innovation to propel digitalization across the entire health ecosystem, spurring him to establish Kent Ridge Health. Dr. Chen started his career with the Singapore Police Force (SPF) as a police officer, where the experience of managing operations formed the foundations of his management skills. He served as SPF's IT consultant on emerging technologies, managing information systems and operations. In this role, he was instrumental in facilitating the overhaul of SPF's transition from outdated organization-wide technologies to cutting edge, cost-effective business solutions that dramatically improved efficiency, decreased expenses, and optimized data integrity and safety. Dr. Chen holds a Doctorate in Business Administration from the University of South Australia and a Bachelor of Science, with honors, in Computer Science from the University of Greenwich.
温伟 Kelvin Chen,自2019年起担任EUDA首席执行官、创始人和执行董事。在此之前的2012年至2017年,陈博士在新加坡最大的上市医疗保健公司Healthway Medical Group(Healthway)工作,该公司拥有100多家医疗诊所。在Healthway任职期间,他最初担任集团营销经理(2012年至2014年),后来晋升为成人专科和CMO部门主管(2014年至2015年),专科部门总经理(2015年),并最终担任副总裁(2015年至2017年),负责企业的运营和增长,为公司2015年出色的收入增长做出了贡献。陈博士在医疗保健和企业销售部门的重组和战略制定中发挥了重要作用,以实现Healthway董事会设定的年度目标。在Healthway任职期间,陈博士看到了传统医疗保健基础设施的差距,以及推动整个健康生态系统数字化的技术创新机会,促使他建立了Kent Ridge Health。陈博士的职业生涯始于新加坡警察部队(SPF),当时他是一名警官,管理业务的经验构成了他管理技能的基础。他曾担任SPF在新兴技术、管理信息系统和运营方面的IT顾问。在担任这一职务期间,他帮助推动了SPF从过时的全组织技术向尖端、高成本效益的业务解决方案过渡的全面改革,这些解决方案显著提高了效率,降低了开支,并优化了数据完整性和安全性。陈博士拥有南澳大利亚大学工商管理博士学位和格林威治大学计算机科学荣誉理学学士学位。
Wei Wen Kelvin Chen,Since 2019, he has served as the Chief Executive Officer and founder as well as the Executive Director at EUDA. Previously, from 2012 to 2017, Dr. Chen worked at Healthway Medical Group (Healthway), the largest listed healthcare company in Singapore with more than 100 medical clinics. While at Healthway, he started off as the Group Marketing Manager (from 2012 to 2014), was promoted to the Head of the Adult Specialist and CMO department (from 2014 to 2015), General Manager of the Specialist Division (2015) and eventually served as the Vice President (from 2015 to 2017), where he was responsible for the enterprise's operations and growth, contributing to its exceptional revenue growth in 2015. Dr, Chen was instrumental in restructuring exercise and strategizing the Healthcare and Corporate Sales division to achieve the annual targets set by the board of Healthway, While at Healthway, Dr. Chen saw the gaps within the traditional healthcare infrastructure and an opportunity for technological innovation to propel digitalization across the entire health ecosystem, spurring him to establish Kent Ridge Health. Dr. Chen started his career with the Singapore Police Force (SPF) as a police officer, where the experience of managing operations formed the foundations of his management skills. He served as SPF's IT consultant on emerging technologies, managing information systems and operations. In this role, he was instrumental in facilitating the overhaul of SPF's transition from outdated organization-wide technologies to cutting edge, cost-effective business solutions that dramatically improved efficiency, decreased expenses, and optimized data integrity and safety. Dr. Chen holds a Doctorate in Business Administration from the University of South Australia and a Bachelor of Science, with honors, in Computer Science from the University of Greenwich.
Steven John Sobak

Steven John Sobak,自2022年3月起担任EUDA的首席财务官。在新加坡和马来西亚,他曾担任首席执行官、首席财务官和首席运营官,在多家医院工作,床位从100张到1500多张不等。多年来,他曾在美国、沙特阿拉伯、新加坡、马来西亚工作,并在中国和印度担任过咨询工作。自2014年以来,Sobak先生一直担任新加坡新项目、绿地和棕地项目以及其他潜在项目的独立医疗顾问,在新加坡为这两个项目提供与医疗保健相关的咨询和咨询服务。他为在中国的项目提供指导和可行性研究准备,以收集管理规划、建设和开放前要求所需的信息、指导和方向。2010年6月至2016年7月,他担任首席运营官(2010年6月至2016年1月)和国家神经科学研究所高级主任(2016年1月至2016年7月)。在此之前,Sobak先生于2009年1月至2015年6月担任新加坡脐带血库首席执行官。同时,他是业务连续性管理研究所的高级讲师。1969年10月至2014年1月,他在新加坡管理大学担任多个职位,包括Singhealth、Healthcura Consulting Pvt Ltd、KK妇幼医院、United Engineers Group(Medical Hall Ltd)、Southern Hospital Group、Tan Tock Seng Hospital Pte Ltd和Hospital Corporation of America/International Inc。在他职业生涯的不同时期,他曾直接负责许多部门的运营,如财务、采购、企业传播、质量服务管理(QSM)、法律、设施和维护运营、生物医疗服务、IT等。他在1989年提出了入院前病人财务咨询的概念,随后新加坡的所有医院都采用了这一概念。他曾监督并负责行政、联合健康、门诊、运营支持等部门的各个部门。他还著有/合著并出版了两本关于医疗保健相关主题的书。索巴克拥有韦恩州立大学金融学硕士学位和管理学学士学位。


Steven John Sobak,has been serving as EUDA's Chief Financial Officer since March 2022. Within Singapore and Malaysia, he has served as Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer at various hospitals ranging from 100 to over 1,500 beds. Over the years he has worked in the US, Saudi Arabia, Singapore, Malaysia and with consulting assignments in China and India. Since 2014, Mr. Sobak has been an Independent Healthcare Consultant for new, greenfield and brownfield projects as well as other potential ventures in Singapore, where he offered healthcare related consulting and advisory services of both. He provided guidance and feasibility study preparations for projects in China to gather required information, guidance and direction for managing the planning, construction and pre-opening requirements. From June 2010 to July 2016, he served as the Chief Operating Officer (June 2010 to January 2016) and Senior Director of National Neuroscience Institute (January 2016 to July 2016). Prior to that, Mr. Sobak was the Chief Executive Officer of Singapore Cord Blood Bank from January 2009 through June 2015. Concurrently, he was the Senior Instructor at Business Continuity Management Institute. From October 1969 through January 2014, he held various positions at Singapore Management University - Singhealth, Healthcura Consulting Pvt Ltd, KK Women's and Children's Hospital, United Engineers Group (Medical Hall Ltd), Southern Hospital Group, Tan Tock Seng Hospital Pte Ltd and Hospital Corporation of America/International Inc. At various times in his career, he had direct operational responsibility for many departments such as Finance, Purchasing, Corporate Communications, Quality Service Management (QSM), Legal, Facilities and Maintenance Operations, Bio-Medical Services, IT, and more. He introduced the concept of Pre-Admission Patient Financial Counseling in 1989, which was subsequently adopted by all hospitals in Singapore. He has supervised and been responsible for various Divisions within the Executive, Allied Health, Outpatient, Operational Support, etc. He has also authored / co-authored and published two books on healthcare related topics. Mr. Sobak holds a Master's Degree in Finance and a Bachelor's Degree in Management, both from Wayne State University.
Steven John Sobak,自2022年3月起担任EUDA的首席财务官。在新加坡和马来西亚,他曾担任首席执行官、首席财务官和首席运营官,在多家医院工作,床位从100张到1500多张不等。多年来,他曾在美国、沙特阿拉伯、新加坡、马来西亚工作,并在中国和印度担任过咨询工作。自2014年以来,Sobak先生一直担任新加坡新项目、绿地和棕地项目以及其他潜在项目的独立医疗顾问,在新加坡为这两个项目提供与医疗保健相关的咨询和咨询服务。他为在中国的项目提供指导和可行性研究准备,以收集管理规划、建设和开放前要求所需的信息、指导和方向。2010年6月至2016年7月,他担任首席运营官(2010年6月至2016年1月)和国家神经科学研究所高级主任(2016年1月至2016年7月)。在此之前,Sobak先生于2009年1月至2015年6月担任新加坡脐带血库首席执行官。同时,他是业务连续性管理研究所的高级讲师。1969年10月至2014年1月,他在新加坡管理大学担任多个职位,包括Singhealth、Healthcura Consulting Pvt Ltd、KK妇幼医院、United Engineers Group(Medical Hall Ltd)、Southern Hospital Group、Tan Tock Seng Hospital Pte Ltd和Hospital Corporation of America/International Inc。在他职业生涯的不同时期,他曾直接负责许多部门的运营,如财务、采购、企业传播、质量服务管理(QSM)、法律、设施和维护运营、生物医疗服务、IT等。他在1989年提出了入院前病人财务咨询的概念,随后新加坡的所有医院都采用了这一概念。他曾监督并负责行政、联合健康、门诊、运营支持等部门的各个部门。他还著有/合著并出版了两本关于医疗保健相关主题的书。索巴克拥有韦恩州立大学金融学硕士学位和管理学学士学位。
Steven John Sobak,has been serving as EUDA's Chief Financial Officer since March 2022. Within Singapore and Malaysia, he has served as Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer at various hospitals ranging from 100 to over 1,500 beds. Over the years he has worked in the US, Saudi Arabia, Singapore, Malaysia and with consulting assignments in China and India. Since 2014, Mr. Sobak has been an Independent Healthcare Consultant for new, greenfield and brownfield projects as well as other potential ventures in Singapore, where he offered healthcare related consulting and advisory services of both. He provided guidance and feasibility study preparations for projects in China to gather required information, guidance and direction for managing the planning, construction and pre-opening requirements. From June 2010 to July 2016, he served as the Chief Operating Officer (June 2010 to January 2016) and Senior Director of National Neuroscience Institute (January 2016 to July 2016). Prior to that, Mr. Sobak was the Chief Executive Officer of Singapore Cord Blood Bank from January 2009 through June 2015. Concurrently, he was the Senior Instructor at Business Continuity Management Institute. From October 1969 through January 2014, he held various positions at Singapore Management University - Singhealth, Healthcura Consulting Pvt Ltd, KK Women's and Children's Hospital, United Engineers Group (Medical Hall Ltd), Southern Hospital Group, Tan Tock Seng Hospital Pte Ltd and Hospital Corporation of America/International Inc. At various times in his career, he had direct operational responsibility for many departments such as Finance, Purchasing, Corporate Communications, Quality Service Management (QSM), Legal, Facilities and Maintenance Operations, Bio-Medical Services, IT, and more. He introduced the concept of Pre-Admission Patient Financial Counseling in 1989, which was subsequently adopted by all hospitals in Singapore. He has supervised and been responsible for various Divisions within the Executive, Allied Health, Outpatient, Operational Support, etc. He has also authored / co-authored and published two books on healthcare related topics. Mr. Sobak holds a Master's Degree in Finance and a Bachelor's Degree in Management, both from Wayne State University.